People living with colorectal cancer that has spread to other areas of the body now have a new therapy option. Unlike so many late-stage cancer treatments, this isn’t an intravenous drug - rather, a tablet.

Colorectal cancer screening rates could be better. Most people just don’t want to mess with the tests or the expenses of these screenings. These already low rates are even lower among poor people, racial minorities and people who don’t speak English very well.

Trillions of bacteria - that's right trillions with a "t" - are found inside the lining of the colon. When inflammation enters the picture, that's when trouble can start. The bacteria and inflammation can team up and become a deadly duo.

The U.S. Food and Drug Administration has approved a new drug to treat advanced colorectal cancer. The medication extends the lives of those living with colorectal cancer that has spread to other organs (metastasized) by about 45 days.

For years, it's been thought that colon cancer differed from rectal cancer. After all, they are two different diseases, occurring in two different organs. Right? Recent research has shown that the two diseases may not be different at all.

Cleaning out the colon is one of the things people hate about having a colonoscopy. A new preparation formula is now available for this unpleasant task.

Some cancers can be eliminated, while some can be put into remission. Others can become like chronic diseases that are managed with medication. One researcher sees the latter group growing in the near future.

Inflammatory bowel diseases ( IBD ) such as ulcerative colitis and Crohn's disease are major risk factors for colorectal cancer. Why? Because these diseases cause constant inflammation - something cancer thrives on.

Not too many people even like to think about what's involved in a colonoscopy. This may be why 40-50 percent of folks just skip the colorectal cancer screening.